Remote sensing of HIV care programmes using centrally collected laboratory results: Can we monitor ART programme effectiveness?

South African Medical Journal

Volumn 102, Issue 6, 2012, Pages 501-505

  Morrow, Carl ^a   Munro, Alison ^c   Wilke, Marisa ^d   Stark, Ruth ^d   Wood, Robin ^b  

^a Institute of Infectious Disease and Molecular Medicine   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Southern African Catholic Bishops' Conference (SACBC) AIDS Office   (South Africa)

^d Catholic Relief Services South Africa   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ARTICLE; CHILD; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; FEMALE; HEALTH CARE; HEALTH CARE QUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PUBLIC HEALTH; REMOTE SENSING; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT RESPONSE; VIRUS LOAD; CD4 LYMPHOCYTE COUNT; HOSPITAL INFORMATION SYSTEM; INFORMATION PROCESSING; METHODOLOGY; TREATMENT OUTCOME;

ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL LABORATORY INFORMATION SYSTEMS; DATA COLLECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84865130984     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.5625     Document Type: Article

References (20)

1. WHO, UNICEF, UNAIDS. Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access: Progress Report 2011. Geneva: WHO, 2011:97. http://www.who.int/hiv/pub/progress_report2011/en/index.html (accessed 13 January 2012).
2. Hoskins S, Weller I, Jahn A, et al. An appraisal of indicators used to monitor the treated population in antiretroviral programmes in low-income countries. AIDS 2010;24(17):2603-2607. [http://dx.doi.org/10.1097%2FQAD.0b013e32833dd0d3]
3. Harries AD, Gomani P, Teck R, et al. Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model. Trans R Soc Trop Med Hyg 2004;98(12):695-701. [http://dx.doi.org/10.1016%2Fj.trstmh.2004.05.002]
4. National Strategic Plan for HIV and AIDS, STIs and TB, 2012-2016: Draft Zero for Consultation. August 2011. http://www.sanac.org.za/files/uploaded/519_NSP%20Draft%20Zero%20110808%20pdf%20%20final.pdf (accessed 9 January 2012).
5. WHO. Global Health Sector Strategy on HIV/AIDS 2011-2015. Geneva: WHO, 2011. http://whqlibdoc.who.int/publications/2011/9789241501651_eng.pdf (accessed 13 January 2012).
6. Mathis S, Khanlari B, Pulido F. Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis. PLoS One 2011;6(7):e22003. Epub 2011 Jul 19. [http://dx.doi.org/10.1371%2Fjournal.pone.0022003]
7. Lawn SD, Myer L, Wood R. Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world? Clin Infect Dis 2005;41(11):1683-1684 [http://dx.doi.org/10.1086%2F498030] [PMID: 16267745]
8. Navalgund Ranganath R, Jayaraman V, Roy PS. Remote sensing applications: An overview. Current Science 2007;93(12):1747-1766. (http://cs-test.ias.ac.in/cs/Downloads/article_42132.pdf)
9. Stover J, Bollinger L. The Costs of Antiretroviral Therapy in Low and Middle Income Countries: Present Commitments and Future Needs. Glastonbury, CT: Futures Institute, 2008. (http://www.futureartcosts.org/The_Costs_of_Anti-Retroviral_Therapy.pdf (accessed 18 November 2011).
10. Wood R, Kaplan R, Bekker LG, Brown S, Rivett U. The utility of pharmacy dispensing data for ART programme evaluation and early identification of patients lost to follow-up. S Afr J HIV Med 2008; Autumn:44-48. (http://www.ajol.info/index.php/sajhivm/article/viewFile/34866/6496)
11. Peter T, Badrichani A, Wu E, et al. Challenges in implementing CD4 testing in resource-limited settings. Cytometry B Clin Cytom 2008;74, Suppl 1:S123-130. [http://dx.doi.org/10.1002%2Fcyto.b.20416]
12. Coetzee D, Hilderbrand K, Boulle A, Draper B, Abdullah F, Goemaere E. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull World Health Organ 2005;83(7):489-494.
13. Tchendjou P, Same-Ekobo C, Nga A. Effectiveness of multidrug antiretroviral regimens to prevent mother-to-child transmission of HIV-1 in routine public health services in Cameroon. PLoS One 2010;5(4):e10411. [http://dx.doi.org/10.1371%2Fjournal.pone.0010411]
14. Das M, Chu PL, Santos GM. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010;5(6):e11068. [http://dx.doi.org/10.1371%2Fjournal.pone.0011068]
15. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009;23(13):1717-1725. [http://dx.doi.org/10.1097%2FQAD.0b013e32832d3b6d]
16. Thakar MR, Abraham PR, Arora S. Establishment of reference CD4+ T cell values for adult Indian population. AIDS Res Ther 2011;8:35. [http://dx.doi.org/10.1186%2F1742-6405-8-35]
17. Dalal RP, Macphail C, Mqhayi M, et al. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 2008;47(1):101-107. [http://dx.doi.org/10.1097%2FQAI.0b013e31815b833a]
18. Government of Malawi Ministry of Health Quarterly HIV Programme Report on HIV Testing and Counselling, Prevention of Mother to Child Transmission and Antiretroviral Therapy: April-June 2011. http://www.hivunitmohmw.org/uploads/Main/Quarterly%20HIV%20Programme%20Report%202011%20Q2.pdf (accessed 18 November 2011).
19. The President's Emergency Plan for AIDS Relief (PEPFAR). Next generation indicators reference guide. http://www.pepfar.gov/documents/organization/81097.pdf (accessed 18 November 2011).
20. Statistics South Africa. StatsOnline. Pretoria: Statistics South Africa, 2010. http://www.statssa.gov.za/publications/statsdownload.asp?PPN=P0302&SCH=4696 (accessed 1 March 2011).